The Value of Combined Application of Oxycodone Hydrochloride Injection and Dexmedetomidine in Anesthesia for LC for Patients with Gallbladder Lesions

Overview

Journal J Healthc Eng

Specialty Biomedical Engineering

Date 2021 Sep 13

PMID 34512931

Citations 3

Authors

Zhantian Wang

Xiaofeng Xu

Affiliations

Soon will be listed here.

Abstract

Objective: To analyze the effect of combined application of oxycodone hydrochloride injection and dexmedetomidine in anesthesia for laparoscopic cholecystectomy (LC) for patients with gallbladder lesions.

Method: 93 patients with gallbladder lesions in our hospital were divided into 2 groups by the random number table method. 46 patients in the control group applied oxycodone hydrochloride injection in anesthesia, and 47 patients in the observation group applied oxycodone hydrochloride injection combined with dexmedetomidine in anesthesia.

Result: The T1 and T2 MAP levels in the observation group were lower than those in the control group ( < 0.05), and the difference between T3 and the control group was not significantly significant ( > 0.05). The T1 to T3 HR level in the observation group were lower than those in the control group ( < 0.05). The rate of excessive sedation (10.64%) and sedation inefficiency (12.77%) in the observation group was lower than that in the control group (28.26% and 30.43%), and the rate of satisfactory sedation (76.60%) was higher than that in the control group (41.30%) ( < 0.05). The postoperative awakening, tracheal tube removal, and first anal venting time were shorter in the observation group than in the control group ( < 0.05). The WHO scores of incisional pain at 6, 12, 24, and 48 hours after the operation were lower in the observation group than in the control group ( < 0.05). The T2 SOD level in the observation group was higher than that in the control group, and the ROS and MDA levels were lower than those in the control group ( < 0.05). The incidence of side effects of anesthetic in the observation group was 17.02%, which was not statistically different from the control group of 13.04% ( > 0.05).

Conclusion: The combined application of oxycodone hydrochloride injection and dexmedetomidine in anesthesia for LC for patients with gallbladder lesions can achieve better sedation and analgesia effect, accelerate postoperative awakening and recovery, and control oxidative stress and fluctuations in signs, without increasing anesthesia-related side effects.

Citing Articles

Outcomes of dexmedetomidine as adjuvant drug in patients undergoing videolaparoscopic cholecystectomy: A randomized and prospective clinical trial.

Silva G, Brandao V, Fiorelli R, Perez M, Mello C, Negrini D Int J Immunopathol Pharmacol. 2023; 37:3946320231196977.

PMID: 37604516 PMC: 10467245. DOI: 10.1177/03946320231196977.

Effects of Dexmedetomidine on Immunomodulation and Pain Control in Videolaparoscopic Cholecystectomies: A Randomized, Two-Arm, Double-Blinded, Placebo-Controlled Trial.

Silva G, Brandao V, Perez M, Lewandrowski K, Fiorelli R J Pers Med. 2023; 13(4).

PMID: 37109010 PMC: 10141731. DOI: 10.3390/jpm13040622.

Retracted: The Value of Combined Application of Oxycodone Hydrochloride Injection and Dexmedetomidine in Anesthesia for LC for Patients with Gallbladder Lesions.

Healthcare Engineering J J Healthc Eng. 2022; 2022:9849756.

PMID: 36465242 PMC: 9712011. DOI: 10.1155/2022/9849756.

References

Namigar T, Serap K, Esra A, Ozgul O, Can O, Aysel A . [The correlation among the Ramsay sedation scale, Richmond agitation sedation scale and Riker sedation agitation scale during midazolam-remifentanil sedation]. Rev Bras Anestesiol. 2017; 67(4):347-354. DOI: 10.1016/j.bjan.2017.03.006. View

Dong W, Chen M, Yang Y, Zhang X, Huang M, Yang X . The effect of dexmedetomidine on expressions of inflammatory factors in patients with radical resection of gastric cancer. Eur Rev Med Pharmacol Sci. 2017; 21(15):3510-3515. View

Ruan X, Mancuso K, Kaye A . Revisiting Oxycodone Analgesia: A Review and Hypothesis. Anesthesiol Clin. 2017; 35(2):e163-e174. DOI: 10.1016/j.anclin.2017.01.022. View

Song J, Wei N, Zhang J, Wang G . Effect of dexmedetomidine combined with oxycodone patient-controlled intravenous analgesia on the levels of inflammatory cytokine in patients with rectal cancer. Pak J Pharm Sci. 2019; 32(3 Special):1381-1385. View

Housset C, Chretien Y, Debray D, Chignard N . Functions of the Gallbladder. Compr Physiol. 2016; 6(3):1549-77. DOI: 10.1002/cphy.c150050. View

Toro A, Mannino M, Bortolussi C, Di Carlo I . Does Converted Open Subtotal Cholecystectomy Definitively Cure a Diseased Gallbladder?. J Am Coll Surg. 2018; 226(3):332. DOI: 10.1016/j.jamcollsurg.2017.11.015. View

Wong H, Lee K . The hourglass gallbladder. Abdom Radiol (NY). 2017; 43(5):1268-1269. DOI: 10.1007/s00261-017-1273-6. View

Lee H, Yoon H, Jin H, Hwang S . Can Dexmedetomidine Influence Recovery Profiles from General Anesthesia in Nasal Surgery?. Otolaryngol Head Neck Surg. 2017; 158(1):43-53. DOI: 10.1177/0194599817733735. View

Davy A, Fessler J, Fischler M, Le Guen M . Dexmedetomidine and general anesthesia: a narrative literature review of its major indications for use in adults undergoing non-cardiac surgery. Minerva Anestesiol. 2017; 83(12):1294-1308. DOI: 10.23736/S0375-9393.17.12040-7. View

10.

Dogan U, Habibi M, Bulbuller N, Ellidag H, Mayir B, Cakir T . Effects of different intraabdominal pressure levels on oxidative stress markers in laparoscopic cholecystectomy. Turk J Surg. 2018; 34(3):212-216. PMC: 6173607. DOI: 10.5152/turkjsurg.2017.3906. View

11.

Kinnunen M, Piirainen P, Kokki H, Lammi P, Kokki M . Updated Clinical Pharmacokinetics and Pharmacodynamics of Oxycodone. Clin Pharmacokinet. 2019; 58(6):705-725. DOI: 10.1007/s40262-018-00731-3. View

12.

Kim S, Donahue T . Laparoscopic Cholecystectomy. JAMA. 2018; 319(17):1834. DOI: 10.1001/jama.2018.3438. View

13.

Deng Y, Liu Y, Tang S, Zhou C, Han X, Xiao W . General Machine Learning Model, Review, and Experimental-Theoretic Study of Magnolol Activity in Enterotoxigenic Induced Oxidative Stress. Curr Top Med Chem. 2017; 17(26):2977-2988. DOI: 10.2174/1568026617666170821130315. View

14.

Ferenchak T . The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review. J Addict Nurs. 2017; 28(4):E1-E2. DOI: 10.1097/JAN.0000000000000205. View

15.

Robinson D, Oliphant M, Dyer R . The "honeycomb" gallbladder. Abdom Radiol (NY). 2018; 44(4):1627-1628. DOI: 10.1007/s00261-018-1850-3. View

16.

Kasciuskeviciute S, Gumbrevicius G, Vendzelyte A, Sciupokas A, Petrikonis K, Kadusevicius E . Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study. Medicina (Kaunas). 2018; 54(2). PMC: 6037262. DOI: 10.3390/medicina54020030. View

17.

Karkkainen J, Saimanen I, Selander T, Aspinen S, Harju J, Juvonen P . Gallstone Patients with Enhanced Oxidative Stress Biomarker Superoxide Dismutase (SOD1) Plasma Levels Have Significantly Lower Number of Postoperative Analgesic Oxycodone Doses: A Prospective Study with Special Reference to Cancer Patients. Anticancer Res. 2018; 38(6):3573-3578. DOI: 10.21873/anticanres.12630. View

18.

Jun J, Kim K, Kim J, Song S . The effects of intranasal dexmedetomidine premedication in children: a systematic review and meta-analysis. Can J Anaesth. 2017; 64(9):947-961. DOI: 10.1007/s12630-017-0917-x. View

19.

Adebimpe W, Faremi A, Nassar S . Effects of treatment on free radicals in patients with pulmonary tuberculosis in South Western Nigeria. Afr Health Sci. 2016; 15(4):1256-61. PMC: 4765427. DOI: 10.4314/ahs.v15i4.26. View

20.

Lee S . Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019; 72(4):323-330. PMC: 6676029. DOI: 10.4097/kja.19259. View